Ex utero intrapartum treatment with placement on extracorporeal membrane oxygenation for fetal thoracic masses. uri icon

Overview

abstract

  • PURPOSE: We describe our experience with fetuses diagnosed with life-threatening chest masses who were delivered by ex utero intrapartum treatment with placement on extracorporeal membrane oxygenation (EXIT-to-ECMO). METHODS: The first fetus presented with a cystic mediastinal mass and enlarging echogenic lungs. Bronchoscopic evaluation during ex utero intrapartum treatment (EXIT) revealed complete airway obstruction secondary to a carinal bronchogenic cyst. The second fetus presented with a massive left congenital cystic adenomatoid malformation. The EXIT procedure was performed because of significant mediastinal shift, severe compression of the normal lung parenchyma, and signs of fetal distress. RESULTS: In both cases, extracorporeal membrane oxygenation (ECMO) was initiated while on placental support. The fetuses were then delivered, and a definitive resection of their thoracic lesions was successfully performed. There were no major perioperative complications. Both children made expedient recoveries without significant cardiopulmonary sequelae. CONCLUSION: To our knowledge, this is the first report describing the successful use of EXIT-to-ECMO as a bridge to definitive resection of large chest masses diagnosed in utero. EXIT-to-ECMO is a novel and effective management strategy for stabilizing patients with profound respiratory compromise secondary to congenital thoracic lesions.

publication date

  • February 1, 2007

Research

keywords

  • Cesarean Section
  • Cystic Adenomatoid Malformation of Lung, Congenital
  • Extracorporeal Membrane Oxygenation
  • Fetal Diseases
  • Thoracotomy

Identity

Scopus Document Identifier

  • 33846555538

Digital Object Identifier (DOI)

  • 10.1016/j.jpedsurg.2006.10.035

PubMed ID

  • 17270561

Additional Document Info

volume

  • 42

issue

  • 2